Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Tobe

Showing results (351-360 of 432) with videos related to

Pageof 44
Sort By:
Life Sciences|January 1, 1989
Effect of synthetic physalaemin on splanchnic circulation in dogsK Takaori, K Inoue, M Kogire, et al.
Human Cell|September 1, 1988
[Clinical therapeutic effect of adoptive immunotherapy using IL-2-cultured autologous lymphocytes]N Kan, T Okino, M Nakanishi, et al.
International Surgery|July 1, 1988
Combined treatment using radiotherapy for carcinoma of the pancreas involving the adjacent vesselsT Manabe, N Baba, A Nonaka, et al.
Biological & Pharmaceutical Bulletin|December 24, 1997
Cloning of the cDNA for a mouse homologue of human PHBP: a novel hyaluronan-binding proteinK Hashimoto, T Tobe, J Sumiya, et al.
Annals of Surgery|August 1, 1987
Plasma cholecystokinin and pancreatic polypeptide response after radical pancreatoduodenectomy with Billroth I and Billroth II type of reconstructionK Inoue, T Tobe, T Suzuki, et al.
Annals of Surgery|March 1, 1987
Usefulness of selective arterial secretin injection test for localization of gastrinoma in the Zollinger-Ellison syndromeM Imamura, K Takahashi, H Adachi, et al.
American Journal of Surgery|November 1, 1982
Pancreatic endocrine function after total gastrectomy and truncal vagotomyT Sudo, K Ishiyama, M Takemoto, et al.
Journal of Biochemistry|March 1, 1996
Primary structure of the pig homologue of human IHRP: inter-alpha-trypsin inhibitor family heavy chain-related proteinK Hashimoto, T Tobe, J Sumiya, et al.
World Journal of Surgery|July 1, 1992
Clinicopathological characteristics of duodenal microgastrinomasM Imamura, M Kanda, K Takahashi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 1, 1990
[Experimental study on the optimal treatment schedule for combination of BRM (immunostimulators, cultured killer cells or interleukin-2) and chemotherapy]N Kan, T Okino, K Satoh, et al.
Pageof 44

Showing results (351-360 of 432) with videos related to

Sort By:
Pageof 44
Life Sciences|January 1, 1989
Effect of synthetic physalaemin on splanchnic circulation in dogsK Takaori, K Inoue, M Kogire, et al.
Human Cell|September 1, 1988
[Clinical therapeutic effect of adoptive immunotherapy using IL-2-cultured autologous lymphocytes]N Kan, T Okino, M Nakanishi, et al.
International Surgery|July 1, 1988
Combined treatment using radiotherapy for carcinoma of the pancreas involving the adjacent vesselsT Manabe, N Baba, A Nonaka, et al.
Biological & Pharmaceutical Bulletin|December 24, 1997
Cloning of the cDNA for a mouse homologue of human PHBP: a novel hyaluronan-binding proteinK Hashimoto, T Tobe, J Sumiya, et al.
Annals of Surgery|August 1, 1987
Plasma cholecystokinin and pancreatic polypeptide response after radical pancreatoduodenectomy with Billroth I and Billroth II type of reconstructionK Inoue, T Tobe, T Suzuki, et al.
Annals of Surgery|March 1, 1987
Usefulness of selective arterial secretin injection test for localization of gastrinoma in the Zollinger-Ellison syndromeM Imamura, K Takahashi, H Adachi, et al.
American Journal of Surgery|November 1, 1982
Pancreatic endocrine function after total gastrectomy and truncal vagotomyT Sudo, K Ishiyama, M Takemoto, et al.
Journal of Biochemistry|March 1, 1996
Primary structure of the pig homologue of human IHRP: inter-alpha-trypsin inhibitor family heavy chain-related proteinK Hashimoto, T Tobe, J Sumiya, et al.
World Journal of Surgery|July 1, 1992
Clinicopathological characteristics of duodenal microgastrinomasM Imamura, M Kanda, K Takahashi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 1, 1990
[Experimental study on the optimal treatment schedule for combination of BRM (immunostimulators, cultured killer cells or interleukin-2) and chemotherapy]N Kan, T Okino, K Satoh, et al.
Pageof 44